|
|
Corporate
-
Overseas Borrowings
Markets
-
Stocks
SPARC converts FCCBs
Mumbai, Dec. 31
Sun Pharma Advanced Research Company Ltd has
informed the BSE that pursuant to clause 10.2 of the
Scheme of Arrangement for demerger sanctioned by the
High court of Gujarat vide its order dated March 1, 2007
issued on March 28, 2007 and as per the Supplementary
Trust Deed dated May 18, 2007, entered into by the
company with Sun Pharmaceutical Industries Ltd (SPIL)
and Citicorp Trustee Co. Ltd, the foreign currency
convertible bond holders of Sun Pharmaceutical
Industries Ltd (SPIL), are entitle d to one equity share of
Re 1 each for every share of Rs 5 each of SPIL allotted to
them on exercise of conversion option of Foreign
Currency Convertible Bonds (FCCBs) of $1,000 each held
by them. Accordingly, the Committee of Directors
(Allotment) of the company at its meeting held on
December 29 allotted 3,39,439 equity shares of Re 1 each
to the bondholders of SPIL upon exercise of option of
conversion for 5,500 Zero Coupon FCCBs of $1,000 each
of SPIL held by them. - Our Bureau
Related Stories:
Sun Pharma’s de-merged arm gets listed at Rs 87.15 on BSE
More Stories on :
Overseas Borrowings |
Stocks |
Pharmaceuticals |
Sun Pharmaceutical Industries Ltd
Article
E-Mail
::
Comment
::
Syndication
::
Printer Friendly Page
|
Stories in this Section
PY-3 resumes production; development plan approved
Pfizer board okays sale of 4 brands to J&J
USFDA nod for Ranbaxy drug
SPARC converts FCCBs
LGB hives forging unit
JSW merger with Southern Steel
Tata Steel Jamshedpur expansion: ‘Promises will be delivered’
Singareni Collieries plans Rs 3,600-cr capex
IOC hopeful of finalising consortium in Turkey project
Shreyas ties up with German Luvomax
Neolite venture with Austrian company
We hope issues relating to 3G are settled soon
Fundamentals strong, we’ll recover: Leyland
Videocon, Jindal Photo, NBCC, Indo Rama plan power foray
Hyundai launching LPG Santro, Getz, Accent
Comfortable profit outlook for IndianOil
Bagalkot Udyog capital reduction
Benz expands CV footprint
|
|